Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Oct;104(2):367–372. doi: 10.1111/j.1476-5381.1991.tb12437.x

Investigation of the effects of IVth ventricular administration of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), on autonomic outflow in the anaesthetized cat.

S L Shepheard 1, D Jordan 1, A G Ramage 1
PMCID: PMC1908558  PMID: 1797303

Abstract

1. The effects of IVth ventricular injections of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on renal, splanchnic and cardiac sympathetic nerve activities, phrenic nerve activity, arterial blood pressure, heart rate, femoral arterial conductance, tracheal and intragastric pressures were investigated in alpha-chloralose anaesthetized, neuromuscular blocked and artificially ventilated cats. 2. Cumulative doses of DOI (80, 160 and 320 nmol kg-1) injected into the IVth ventricle caused an increase in mean arterial blood pressure, a fall in femoral arterial conductance, an increase in tracheal pressure and a decrease in the rate of phrenic nerve bursts but did not affect any of the other variables recorded. 3. Even after i.v. administration of the peripheral 5-HT2 antagonist BW501C67 (2 mg kg-1) following the highest dose of DOI there was still a significant pressor response, a fall in femoral arterial conductance and small increase in tracheal pressure. 4. In control experiments, intravenous infusion of noradrenaline to raise blood pressure to the levels obtained during the cumulative doses of DOI caused large falls in renal, splanchnic and cardiac nerve activities which were all significantly lower than those recorded during the cumulative doses of DOI. 5. The results of this study provide evidence for a brainstem site of action of DOI in producing hypertension and further support the hypothesis that central 5-HT2 receptors are involved in the control of skeletal muscle and skin vascular beds.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. L., Wood K. L. Systemic baclofen stimulates gastric motility and secretion via a central action in the rat. Br J Pharmacol. 1986 Nov;89(3):461–467. doi: 10.1111/j.1476-5381.1986.tb11145.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clement M. E., McCall R. B. Studies on the site and mechanism of the sympathoexcitatory action of 5-HT2 agonists. Brain Res. 1990 May 7;515(1-2):299–302. doi: 10.1016/0006-8993(90)90610-n. [DOI] [PubMed] [Google Scholar]
  3. Fuller R. W., Kurz K. D., Mason N. R., Cohen M. L. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Eur J Pharmacol. 1986 Jun 5;125(1):71–77. doi: 10.1016/0014-2999(86)90084-1. [DOI] [PubMed] [Google Scholar]
  4. Gillis R. A., Hill K. J., Kirby J. S., Quest J. A., Hamosh P., Norman W. P., Kellar K. J. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exp Ther. 1989 Feb;248(2):851–857. [PubMed] [Google Scholar]
  5. Holtman J. R., Jr, Anastasi N. C., Norman W. P., Dretchen K. L. Effect of electrical and chemical stimulation of the raphe obscurus on phrenic nerve activity in the cat. Brain Res. 1986 Jan 8;362(2):214–220. doi: 10.1016/0006-8993(86)90446-4. [DOI] [PubMed] [Google Scholar]
  6. Holtman J. R., Jr, Dick T. E., Berger A. J. Serotonin-mediated excitation of recurrent laryngeal and phrenic motoneurons evoked by stimulation of the raphe obscurus. Brain Res. 1987 Aug 4;417(1):12–20. doi: 10.1016/0006-8993(87)90174-0. [DOI] [PubMed] [Google Scholar]
  7. King K. A., Holtman J. R., Jr Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm and larynx. J Pharmacol Exp Ther. 1990 Feb;252(2):665–674. [PubMed] [Google Scholar]
  8. Lalley P. M. Serotoninergic and non-serotoninergic responses of phrenic motoneurones to raphe stimulation in the cat. J Physiol. 1986 Nov;380:373–385. doi: 10.1113/jphysiol.1986.sp016291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Laubie M., Drouillat M., Dabiré H., Cherqui C., Schmitt H. Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs. Eur J Pharmacol. 1989 Feb 7;160(3):385–394. doi: 10.1016/0014-2999(89)90094-0. [DOI] [PubMed] [Google Scholar]
  10. Mandal A. K., Kellar K. J., Friedman E., Pineo S. V., Hamosh P., Gillis R. A. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil. J Pharmacol Exp Ther. 1989 Nov;251(2):563–570. [PubMed] [Google Scholar]
  11. Mandal A. K., Kellar K. J., Norman W. P., Gillis R. A. Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow. Circ Res. 1990 Nov;67(5):1267–1280. doi: 10.1161/01.res.67.5.1267. [DOI] [PubMed] [Google Scholar]
  12. Mawson C., Whittington H. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol. 1970 May;39(1):223P–224P. [PMC free article] [PubMed] [Google Scholar]
  13. McCall R. B., Harris L. T. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge. Eur J Pharmacol. 1988 Jun 22;151(1):113–116. doi: 10.1016/0014-2999(88)90698-x. [DOI] [PubMed] [Google Scholar]
  14. McCall R. B., Patel B. N., Harris L. T. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J Pharmacol Exp Ther. 1987 Sep;242(3):1152–1159. [PubMed] [Google Scholar]
  15. Oberg B. Overall cardiovascular regulation. Annu Rev Physiol. 1976;38:537–570. doi: 10.1146/annurev.ph.38.030176.002541. [DOI] [PubMed] [Google Scholar]
  16. Ramage A. G. Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):601–607. doi: 10.1007/BF00165623. [DOI] [PubMed] [Google Scholar]
  17. Ramage A. G. The effect of prazosin, indoramin and phentolamine on sympathetic nerve activity. Eur J Pharmacol. 1984 Nov 27;106(3):507–513. doi: 10.1016/0014-2999(84)90054-2. [DOI] [PubMed] [Google Scholar]
  18. Ramage A. G. The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity. Eur J Pharmacol. 1985 Jul 31;113(3):295–303. doi: 10.1016/0014-2999(85)90076-7. [DOI] [PubMed] [Google Scholar]
  19. Ramage A. G., Wilkinson S. J. Evidence that different regional sympathetic outflows vary in their sensitivity to the sympathoinhibitory actions of putative 5-HT1A and alpha 2-adrenoceptor agonists in anaesthetized cats. Br J Pharmacol. 1989 Dec;98(4):1157–1164. doi: 10.1111/j.1476-5381.1989.tb12660.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Vayssettes-Courchay C., Bouysset F., Verbeuren T. J., Laubie M., Schmitt H. Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. Eur J Pharmacol. 1991 Jan 17;192(3):389–395. doi: 10.1016/0014-2999(91)90230-n. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES